Skip to Content

A176 150 (Fluvoxamine Maleate Extended-Release 150 mg)

Pill with imprint A176 150 is Purple / White, Capsule-shape and has been identified as Fluvoxamine Maleate Extended-Release 150 mg. It is supplied by Par Pharmaceutical Inc..

Fluvoxamine is used in the treatment of anxiety and stress; obsessive compulsive disorder; social anxiety disorder and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy. Fluvoxamine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A176 150

Fluvoxamine maleate extended-release 150 mg A176 150
Fluvoxamine maleate extended-release 150 mg A176 150
Fluvoxamine maleate extended-release 150 mg A176 150

Fluvoxamine Maleate Extended-Release

Imprint
A176 150
Strength
150 mg
Color
Purple / White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective serotonin reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc.
National Drug Code (NDC)
10370-0176

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.